KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome
Human Molecular Genetics · 2025
DOI: 10.1093/hmg/ddaf082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2025. Verfasst von Amber S E van Oirsouw und 30 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Life Sciences, Utrecht University, Heidelberglaan 8, 3584 CS Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Jumonji Domain-Containing Histone Demethylases, Neurodevelopmental Disorders, F-Box Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stichting 12q, US NINDS, NINDS NIH HHS.
Abstract (Originalsprache)
Rare variants affecting the epigenetic regulator KDM2B cause a recently delineated neurodevelopmental disorder. Interestingly, we previously identified both a general KDM2B-associated episignature and a subsignature specific to variants in the DNA-binding CxxC domain. In light of the existence of a distinct subsignature, we set out to determine if KDM2B CxxC variants are associated with a unique phenotype and disease mechanism. We recruited individuals with heterozygous CxxC variants and assessed the variants’ effect on protein expression and DNA-binding ability. We analyzed clinical data from 19 individuals, including ten previously undescribed individuals with seven novel CxxC variants. The core phenotype of the KDM2B-CxxC cohort is more extensive as compared to that of individuals with KDM2B haploinsufficiency. All individuals with CxxC variants presented with developmental delay, mainly in the speech and motor domain, in addition to variable intellectual disability and mild facial dysmorphism. Congenital heart defects were observed in up to 78% of individuals, with additional common findings including musculoskeletal, ophthalmological, and urogenital anomalies, as well as behavioral challenges and feeding difficulties. Functional assays revealed that while mutant KDM2B protein with CxxC variants can be expressed in vitro, its DNA-binding ability is significantly reduced compared to wildtype. This study shows that KDM2B CxxC variants cause a distinct neurodevelopmental syndrome, possibly through a molecular mechanism different from haploinsufficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate School of Life Sciences, Utrecht University, Heidelberglaan 8, 3584 CS Utrecht, The Netherlands.
- UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
- Department of Genetics, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
- Oncode Institute and Center for Molecular Medicine, University Medical Center Utrecht, Utrecht University, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.
- Pediatric Genetics Unit, Schneider Children's Medical Centerl, 14 Kaplan St., Petah Tikva 4920235, Israel.
- Department of Clinical Genetics, Erasmus MC University Medical Center, Dr. Molewaterplein 50, Rotterdam 3000 CA, The Netherlands.
Förderung
- Stichting 12q
- US NINDS
- NINDS NIH HHS
- Netherlands Organisation for Scientific Research
- Wellcome Trust
- Wilhelmina Children's Hospital Research Fund
- Wilhelmina Children’s Hospital Research Fund
Zitieren
APA
van Oirsouw, A. S. E., Hadders, M. A., Koetsier, M., Peters, E. D. J., Assia Batzir, N., Barakat, T. S., Baralle, D., Beil, A., Bonnet-Dupeyron, M. N., Boone, P. M., Bouman, A., Carere, D. A., Cogne, B., Dunnington, L., Farach, L. S., Genetti, C. A., Isidor, B., Januel, L., Joshi, A., …, & Oegema, R. (2025). KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddaf082
Vancouver
van Oirsouw ASE, Hadders MA, Koetsier M, Peters EDJ, Assia Batzir N, Barakat TS, et al. KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome. Human Molecular Genetics. 2025. doi:10.1093/hmg/ddaf082
BibTeX
@article{vanOirsouw2025,
author = {van Oirsouw, Amber S E and Hadders, Michael A and Koetsier, Martijn and Peters, Edith D J and Assia Batzir, Nurit and Barakat, Tahsin Stefan and Baralle, Diana and Beil, Adelyn and Bonnet-Dupeyron, Marie-Noëlle and Boone, Philip M and Bouman, Arjan and Carere, Deanna Alexis and Cogne, Benjamin and Dunnington, Leslie and Farach, Laura S and Genetti, Casie A and Isidor, Bertrand and Januel, Louis and Joshi, Aakash and Lahiri, Nayana and Lee, Kristen N and Maya, Idit and McEntagart, Meriel and Northrup, Hope and Pujalte, Mathilde and Richardson, Kate and Walker, Susan and Koeleman, Bobby P C and Alders, Mariëlle and van Jaarsveld, Richard H and Oegema, Renske},
title = {KDM2B variants in the CxxC domain impair its DNA-binding ability and cause a distinct neurodevelopmental syndrome},
journal = {Human Molecular Genetics},
year = {2025},
doi = {10.1093/hmg/ddaf082}
}
EUVIMED